Current evidence supports vitamin D₃ as a safe, cost-effective, and promising adjuvant strategy in oncology; however, its routine clinical application requires validation through well-designed, large-scale randomized controlled trials to establish optimal dosing strategies, identify responsive patient populations, and confirm long-term efficacy and safety.
Traditionally, vitamin D has been recognized primarily for its role in regulating calcium homeostasis and supporting skeletal integrity. Current research has found growing evidences of other biological processes involving vitamin D that contribute to cancer etiology and pathogenesis. Recently, increasing scientific att...
A. Baothman, O. Shaker, Duaa Eliwa et al.· Journal of Investigative Med...· 0 citations
Vitamin D3 (cholecalciferol) is a steroid prohormone synthesized in the skin as a result of UV-B light exposure or by dietary intake. In addition to the already proven action on calcium phosphate metabolism and bone physiology, there is an increasing body of research showing that vitamin D3 may impact carcinogenesis an...
N. Brzozowska, Eliza Mędrek, Sara Awad et al.· International Journal of Inn...· 0 citations
This review demonstrates the therapeutic potential of phytochemicals as multitarget agents in pancreatic cancer, emphasizing their molecular mechanisms, pharmacological properties, and translational relevance.
Md. Rezaul Islam, Abdur Rauf, F. Shourav et al.· Phytotherapy Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.